UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

____________________

 

FORM 15

____________________

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number:  0-54717

 

BIONIK LABORATORIES CORP.

(Exact name of registrant as specified in its charter)

 

80 Coolidge Hill Road, Watertown, MA 02472

(617) 926-4800

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

 

Common Stock, $0.001 par value per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1) ¨
Rule 12g-4(a)(2) x
Rule 12h-3(b)(1)(i) ¨
Rule 12h-3 (b)(1)(ii) x
Rule 15d-6 ¨
Rule 15d-22(b) ¨

  

Approximate number of holders of record as of the certification or notice date:  310

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Bionik Laboratories Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Dated:  June 30, 2023

 

  BIONIK LABORATORIES CORP.
     
     
  By:   /s/ Rich Russo Jr.
    Name:  Rich Russo Jr.
    Title:    Chief Executive Officer

 

 

 

 

 

 

Bionik Laboratories (CE) (USOTC:BNKL)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Bionik Laboratories (CE) Charts.
Bionik Laboratories (CE) (USOTC:BNKL)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Bionik Laboratories (CE) Charts.